An evolving role for oral fluoropyrimidine drugs

被引：15

作者：

Diasio, RB ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 04期

关键词：

D O I：

10.1200/JCO.2002.20.4.894

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：894 / 896

页数：3

共 20 条

[1] 5-ETHYNYLURACIL (776C85) - A POTENT MODULATOR OF THE PHARMACOKINETICS AND ANTITUMOR EFFICACY OF 5-FLUOROURACIL [J].

BACCANARI, DP ;

DAVIS, ST ;

KNICK, VC ;

SPECTOR, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11064-11068

[2] Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil [J].

Baker, SD ;

Diasio, RB ;

O'Reilly, S ;

Lucas, VS ;

Khor, SP ;

Sartorius, SE ;

Donehower, RC ;

Grochow, LB ;

Spector, T ;

Hohneker, JA ;

Rowinsky, EK .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :915-926

[3] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer [J].

Blum, JL ;

Jones, SE ;

Buzdar, AU ;

LoRusso, PM ;

Kuter, I ;

Vogel, C ;

Osterwalder, B ;

Burger, HU ;

Brown, CS ;

Griffin, T .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :485-493

[4]

BLUM JL, 1999, P AN M AM SOC CLIN, V18, pA107

[5] Improving fluorouracil chemotherapy with novel orally administered fluoropyrimidines [J].

Diasio, RB .

DRUGS, 1999, 58 (Suppl 3) :119-126

[6] The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil [J].

Diasio, RB ;

Johnson, MR .

PHARMACOLOGY, 2000, 61 (03) :199-203

[7] Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study [J].

Falcone, A ;

Allegrini, G ;

Lencioni, M ;

Pfanner, E ;

Brunetti, I ;

Cianci, C ;

Galli, C ;

Masi, G ;

Antonuzzo, A ;

Conte, P .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) :159-163

[8]

HESLIN MJ, 2000, P AN M AM SOC CLIN, V19, pA176

[9] Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study [J].

Hoff, PM ;

Ansari, R ;

Batist, G ;

Cox, J ;

Kocha, W ;

Kuperminc, M ;

Maroun, J ;

Walde, D ;

Weaver, C ;

Harrison, E ;

Burger, HU ;

Osterwalder, B ;

Wang, AO ;

Wong, R .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2282-2292

[10]

Ishikawa T, 1998, CANCER RES, V58, P685

← 1 2 →